Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV Infection

Affiliations

¹ School of Health and Rehabilitation Sciences, Division of Medical Laboratory Science, Ohio State University, 453W. 10th Ave., 535A Atwell Hall, Columbus, OH 43210, United States. Electronic address: Nicholas.funderburg@osumc.edu.

Comment

Nicholas T Funderburg. EBioMedicine. 2016 Jun.

. 2016 Jun:8:16-17.

doi: 10.1016/j.ebiom.2016.05.012. Epub 2016 May 13.

¹ School of Health and Rehabilitation Sciences, Division of Medical Laboratory Science, Ohio State University, 453W. 10th Ave., 535A Atwell Hall, Columbus, OH 43210, United States. Electronic address: Nicholas.funderburg@osumc.edu.

No abstract available

Comment on

One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.
Psomas C, Younas M, Reynes C, Cezar R, Portalès P, Tuaillon E, Guigues A, Merle C, Atoui N, Fernandez C, Le Moing V, Barbuat C, Marin G, Nagot N, Sotto A, Eliaou JF, Sabatier R, Reynes J, Corbeau P. Psomas C, et al. EBioMedicine. 2016 Jun;8:265-276. doi: 10.1016/j.ebiom.2016.05.008. Epub 2016 May 10. EBioMedicine. 2016. PMID: 27428436 Free PMC article.

1. Emery S., Neuhaus J.A., Phillips A.N. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J. Infect. Dis. 2008;197:1133–1144. - PubMed
1. Hunt P.W., Sinclair E., Rodriguez B. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 2014;210:1228–1238. - PMC - PubMed
1. Kalayjian R.C., Machekano R.N., Rizk N. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J. Infect. Dis. 2010;201:1796–1805. - PMC - PubMed
1. Kuller L.H., Tracy R., Belloso W. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5 - PMC - PubMed
1. Lederman M.M., Funderburg N.T., Sekaly R.P., Klatt N.R., Hunt P.W. Residual immune dysregulation syndrome in treated HIV infection. Adv. Immunol. 2013;119:51–83. - PMC - PubMed